featured
ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients
Risk for patients in rivaroxaban group reduced during the on-treatment period
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.